Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M110235200 on December 27, 2001

J. Biol. Chem., Vol. 277, Issue 10, 8226-8234, March 8, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/10/8226    most recent
M110235200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laprise, P.
Right arrow Articles by Rivard, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laprise, P.
Right arrow Articles by Rivard, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Phosphatidylinositol 3-Kinase Controls Human Intestinal Epithelial Cell Differentiation by Promoting Adherens Junction Assembly and p38 MAPK Activation*

Patrick LapriseDagger, Pierre Chailler, Mathieu Houde, Jean-François Beaulieu, Marie-Josée Boucher, and Nathalie Rivard§

From the Canadian Institutes of Health Research Group on Functional Development and Physiopathology of the Digestive Tract, Département d'Anatomie et Biologie Cellulaire, Faculté de Médecine, Université de Sherbrooke, Sherbrooke, Québec J1H 5N4, Canada

Received for publication, October 24, 2001, and in revised form, December 21, 2001

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The signaling pathways mediating human intestinal epithelial cell differentiation remain largely undefined. Phosphatidylinositol 3-kinase (PI3K) is an important modulator of extracellular signals, including those elicited by E-cadherin-mediated cell-cell adhesion, which plays an important role in maintenance of the structural and functional integrity of epithelia. In this study, we analyzed the involvement of PI3K in the differentiation of human intestinal epithelial cells. We showed that inhibition of PI3K signaling in Caco-2/15 cells repressed sucrase-isomaltase and villin protein expression. Morphological differentiation of enterocyte-like features in Caco-2/15 cells such as epithelial cell polarity and brush-border formation were strongly attenuated by PI3K inhibition. Immunofluorescence and immunoprecipitation experiments revealed that PI3K was recruited to and activated by E-cadherin-mediated cell-cell contacts in confluent Caco-2/15 cells, and this activation appears to be essential for the integrity of adherens junctions and association with the cytoskeleton. We provide evidence that the assembly of calcium-dependent adherens junctions led to a rapid and remarkable increase in the state of activation of Akt and p38 MAPK pathways and that this increase was blocked in the presence of anti-E-cadherin antibodies and PI3K inhibitor. Therefore, our results indicate that PI3K promotes assembly of adherens junctions, which, in turn, control p38 MAPK activation and enterocyte differentiation.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The epithelium of the small intestine is characterized by its rapid and constant renewal. This process involves cell generation and migration from the stem cell population located at the bottom of the crypt to the extrusion of terminally differentiated cells at the tip of the villus (1). Thus, the crypt is mainly composed of proliferative and poorly differentiated cells, whereas the villus is lined with functional absorptive, goblet, and endocrine cells (1). The molecular and cellular mechanisms responsible for the fine coordination between proliferation, migration, and differentiation along the crypt-villus axis are still largely unknown.

E-cadherin-mediated cell-cell attachment plays an important role in the differentiation, polarization, and homeostasis of many epithelia (2-4). Cadherins are responsible for cell-cell adhesion through a calcium-dependent interaction of their extracellular domains. Their cytoplasmic tails are linked to the cytoskeleton through a complex of proteins that includes alpha -, beta -, and gamma -catenins. This link is involved in the strengthening of cell-cell adhesion and in the cohesion of epithelial tissues (5). The importance of cadherins in the renewal of the intestinal epithelium has been demonstrated in vivo in two mouse models. Overexpression of E-cadherin in the crypts of the small intestine reduces cell proliferation and migration (6). Conversely, expression of a dominant-negative N-cadherin leads to over-proliferation, uncoordinated differentiation, and a Crohn's disease phenotype (7).

The intracellular signaling pathways that transmit extracellular cues for epithelial differentiation along the crypt-villus axis of the intestine remain poorly defined. We recently reported that p38 MAPK1 plays a crucial role in intestinal epithelial cell differentiation by enhancing the transactivation capacity of CDX2 (8), an intestine-specific homeobox gene product well known for its broad effect on enterocyte differentiation (9). However, the upstream signaling pathways activating p38 MAPK in committed intestinal cells induced to differentiate remain to be defined. Interestingly, in vitro experiments have shown that the establishment of cell-cell contacts in intestinal cell cultures could be a critical step in initiating p38 MAPK action (8), cell cycle arrest (10, 11), and induction of the differentiation process (8, 12-15).

An important role for p38 MAPK in various mammalian cell differentiation processes has recently been proposed (16). For instance, differentiation of C2C12 and L8 myoblasts into myotubes has been found to be mediated by p38 activation (17, 18). Although this skeletal muscle differentiation requires phosphatidylinositol 3-kinase (PI3K), it is not yet clear whether PI3K and p38 MAPK act in a common pathway (19, 20). The PI3K family members are lipid kinases that phosphorylate phosphoinositides at position 3 of the inositol ring (21), acting as membrane anchors that locate and activate pleckstrin homology domain-containing effectors such as the well characterized serine/threonine kinase Akt (22). Class I PI3Ks are generally composed of a p85 regulatory subunit and a p110 catalytic subunit (21). This class of PI3Ks can be activated by a wide variety of extracellular stimuli, including those elicited by E-cadherin-mediated cell-cell adhesion (23).

In this study, the role and regulation of PI3K in intestinal epithelial cells were investigated. Using several approaches, we demonstrated that PI3K is necessary for the functional and morphological differentiation of intestinal epithelial cells. We also found that PI3K is recruited to and activated by E-cadherin-mediated cell-cell contacts in confluent Caco-2/15 cultures and that this activation appears to be essential for the integrity of the adherens junctions and the association of their components with the cytoskeleton. Finally, we have provided evidence that the assembly of the adherens junctions stimulates Akt and p38 MAPK in a PI3K-dependent manner.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- [gamma -32P]ATP and the enhanced chemiluminescence immunodetection system (ECL) were obtained from Amersham Biosciences, Inc. (Baie d'Urfé, Québec, Canada). Antiserum that specifically recognizes p38alpha MAPK on Western blots (24) was a kind gift from Dr. J. Landry (Université Laval, Laval, Québec). Monoclonal antibody HSI-14 (25) against sucrase-isomaltase was kindly provided by Dr. A. Quaroni (Cornell University, Ithaca, NY). Monoclonal antibody CII10 recognizing the 89-kDa apoptotic fragment and the 113-kDa non-cleaved fragment of poly(ADP-ribose) polymerase was a kind gift from Dr. G. G. Poirier (Université Laval). Fluorescein isothiocyanate-labeled goat anti-rabbit IgG and rhodamine-labeled goat anti-mouse IgG were from Roche Molecular Biochemicals (Laval). Antibodies raised against villin, E-cadherin (used in Western blotting and immunofluorescence), and beta -catenin were purchased from Transduction Laboratories (Mississauga, Ontario, Canada). Antibody recognizing the phosphorylated and active form of p38 MAPK was from Promega (Nepean, Ontario). Antibody directed against the PI3K p85 regulatory subunit was obtained from Upstate Biotechnology, Inc. (Lake Placid, NY). Anti-Akt and anti-phospho-Akt(Ser473) antibodies were purchased from Cell Signaling (Mississauga). Antibody directed against total actin was from Roche Molecular Biochemicals. The anti-ZO-1 antibody and the anti-E-cadherin antibody used in antibody inhibition experiments were from Zymed Laboratories Inc. (South San Francisco, CA). The specific inhibitor of PI3K (LY294002) was purchased from Calbiochem (Mississauga). All other materials were obtained from Sigma (Oakville, Ontario) unless otherwise stated.

Cell Culture-- The Caco-2/15 cell line was obtained from Dr. A. Quaroni. This clone of the parent Caco-2 cell line (HTB37; American Type Culture Collection, Manassas, VA) has been extensively characterized elsewhere (13, 15, 26) and was originally selected for expressing the highest level of sucrase-isomaltase among 16 clones obtained by random cloning. This cell line was routinely cultured in plastic dishes in Dulbecco's modified Eagle's medium (Invitrogen, Burlington, Ontario) containing 10% fetal bovine serum, 4 mM glutamine, 20 mM HEPES, 50 units/ml penicillin, and 50 µg/ml streptomycin. Caco-2/15 cells were used between passages 53 and 78. Studies were performed on cultures at subconfluence (50%) and confluence and between days 2 and 15 post-confluence.

Protein Expression and Immunoblotting-- Cells were lysed in SDS sample buffer (62.5 mM Tris-HCl (pH 6.8), 2.3% SDS, 10% glycerol, 5% beta -mercaptoethanol, and 0.005% bromphenol blue). Proteins (10-50 µg) from whole cell lysates were separated by SDS-PAGE on 7.5 or 10% gels. Proteins were detected immunologically following electrotransfer onto nitrocellulose membranes (Amersham Biosciences, Inc.). Protein and molecular mass markers (Bio-Rad, Mississauga) were revealed by Ponceau red staining. Membranes were blocked in PBS containing 5% powdered milk and 0.05% Tween 20 for at least 1 h at 25 °C. Membranes were then incubated overnight at 4 °C with primary antibodies in blocking solution and then with horseradish peroxidase-conjugated goat anti-mouse or anti-rabbit IgG (1:1000) for 1 h. The blots were visualized using the Amersham Biosciences ECL system. Protein concentrations were measured using a modified Lowry procedure with bovine serum albumin as the standard (27).

Expression Vectors and Reporter Constructs-- The sucrase-isomaltase reporter construct (provided by Dr. P. G. Traber, University of Pennsylvania, Philadelphia) used for luciferase assays contained the human sucrase-isomaltase promoter from residues -183 to +54 cloned upstream of the luciferase gene of the pGL2 reporter construct as described previously (9). The pRL-SV40 Renilla luciferase vector was from Promega. Expression vectors for a constitutively active form of PI3K (p110*) and a dominant-negative form of PI3K (Delta p85) were obtained from Dr. Julian Downward (Imperial Cancer Research Fund, London, United Kingdom) and Dr. Masato Kasuga (Kobe University School of Medicine, Kobe, Japan). Green fluorescent protein (GFP) (CLONTECH, Palo Alto, CA) was subcloned into the expression vector pLHCX (CLONTECH).

Transient Transfections-- Newly confluent Caco-2/15 cells grown on glass coverslips in six-well plates were cotransfected by lipofection (LipofectAMINE 2000, Invitrogen) with 0.5 µg of pLHCX-GFP and 0.5 µg of pcDNA3 containing or not the dominant-negative form of PI3K (Delta p85). Two days following transfection, cells were fixed for GFP fluorescence and immunofluorescence with either anti-E-cadherin antibody or anti-total actin antibody.

Luciferase Assays-- Confluent Caco-2/15 cells grown in 24-well plates were transfected by lipofection (LipofectAMINE 2000) as described previously (15) with 0.1 µg of sucrase-isomaltase/luciferase reporter. One day following transfection, cells were treated with 0, 1, 2, 5, 10, and 20 µM LY294002 for 24 h, and luciferase activity was measured. In other experiments, the sucrase-isomaltase reporter gene vector was cotransfected with 0.1 µg of pcDNA3 containing or not the dominant-negative (Delta p85) or constitutively active (p110*) form of PI3K. Luciferase activity was measured 36 h after transfection. The pRL-SV40 Renilla luciferase vector was used as a control for transfection efficiency.

Electron Microscopy-- Cell cultures were rinsed with PBS, prefixed for 15 min with a 1:1 mixture of culture medium (Dulbecco's modified Eagle's medium) and freshly prepared 2.8% glutaraldehyde in cacodylate buffer (0.1 M cacodylate and 7.5% sucrose), and then fixed for 30 min with 2.8% glutaraldehyde at room temperature. After two rinses, specimens were post-fixed for 60 min with 2% osmium tetroxide in cacodylate buffer. The cells were then dehydrated using increasing ethanol concentrations (40, 70, 90, 95, and 100%; three times each) and covered twice for 3 h with a thin layer of Araldite 502 resin (for ethanol substitution). Finally, the resin was allowed to polymerize at 60 °C for 48 h. The specimens were detached from the plastic vessels, inverted in embedding molds, covered with Araldite 502, and reincubated at 60 °C for 48 h. Thin sections were prepared using an ultramicrotome, contrasted with lead citrate and uranyl acetate, and observed in a blind fashion on a Jeol 100 CX transmission electron microscope. All reagents were purchased from Electron Microscopy Sciences (Cedarlane, Hornby, Ontario).

Isolation of Cytoskeleton-associated Proteins-- First, the cells were washed twice with ice-cold PBS, and then soluble proteins were extracted on ice with cold lysis/cytoskeleton stabilization buffer (0.5% Triton X-100, 50 mM NaCl, 10 mM PIPES (pH 6.8), 300 mM sucrose, and 3 mM MgCl2). The cytoskeleton-associated proteins (insoluble fraction) were harvested by centrifugation (13,000 rpm at 4 °C for 20 min) and solubilized in SDS buffer (15 mM Tris (pH 7.5), 5 mM EDTA, 2.5 mM EGTA, and 1% SDS) (28). Finally, E-cadherin and beta -catenin levels were determined by immunoblotting of the cytoskeleton and total fractions (equal amounts of the soluble and cytoskeleton fractions).

Co-immunoprecipitation Experiments-- Cells were washed twice with ice-cold PBS and lysed in chilled lysis buffer (150 mM NaCl, 1 mM EDTA, 40 mM Tris (pH 7.6), 1% Triton X-100, 0.1 mM phenylmethylsulfonyl fluoride, 10 µg/ml leupeptin, 1 µg/ml pepstatin, 10 µg/ml aprotinin, 0.1 mM orthovanadate, and 40 mM beta -glycerophosphate). Cell lysates were then cleared of cellular debris by centrifugation. Primary antibodies were added to 600 µg of each cell lysate and incubated for 2 h at 4 °C under agitation. Forty µg of protein A-Sepharose (Amersham Biosciences, Inc.) were subsequently added for 1 h (4 °C under agitation). Immunocomplexes were then harvested by centrifugation and washed four times with ice-cold lysis buffer. Proteins were solubilized with Laemmli buffer and separated by SDS-PAGE.

Immunofluorescence Microscopy-- Caco-2/15 cells grown on sterile glass coverslips were washed twice with ice-cold PBS. Cultures were then fixed with 30% methanol and 70% acetone for 15 min at -20 °C, permeabilized with a solution of 0.1% of Triton X-100 in PBS for 10 min, and blocked with PBS and 2% bovine serum albumin for 20 min at room temperature. Cells were finally immunostained for 1 h with the primary antibody and for 30 min with the secondary antibody. For F-actin staining, fixed cells were incubated with 1 µg/ml fluorescein isothiocyanate-phalloidin for 30 min. For total actin staining, fixed cells were incubated with antibody raised against total actin and then with rhodamine-labeled goat anti-mouse IgG. Negative controls (no primary antibody) were included in all experiments.

p38 MAPK Assay-- Cells were lysed for 10 min on ice with 1 ml/dish lysis buffer (150 mM NaCl, 1 mM EDTA, 40 mM Tris (pH 7.60), and 1% Triton X-100) supplemented with protease inhibitors (0.1 mM phenylmethylsulfonyl fluoride, 10 µg/ml leupeptin, 1 µg/ml pepstatin, and 10 µg/ml aprotinin) and phosphatase inhibitors (0.1 mM orthovanadate and 40 mM beta -glycerophosphate). p38 MAPK was immunoprecipitated from 400 µg of cell lysate. Immunocomplexes were then washed four times with ice-cold lysis buffer and three times with ice-cold kinase buffer (20 mM p-nitrophenyl phosphate, 10 mM MgCl2, 1 mM dithiothreitol, and 30 mM HEPES (pH 7.4)) prior to the kinase assay. The kinase reaction was initiated by incubating the immunocomplexes at 30 °C in the presence of myelin basic protein and [gamma -32P]ATP at 2 µg and 2 µCi/assay, respectively. After 30 min, the reaction was stopped by adding Laemmli buffer. Radiolabeled substrates were separated from immunocomplexes by SDS-12.5% PAGE and autoradiographed. Incorporation of 32P by myelin basic protein was linear over the course of the kinase assay.

Inhibition of E-cadherin-mediated Cell-Cell Contacts-- Day 2 post-confluent Caco-2/15 cells were serum-starved for 16 h in Dulbecco's modified Eagle's medium supplemented with 20 mM HEPES, 50 units/ml penicillin, 50 µg/ml streptomycin, and 4 mM glutamine. The adherens junctions were then disrupted by treatment with 4 mM EGTA for 30 min at 37 °C. Intercellular contacts were subsequently allowed to re-establish by restoration of the extracellular calcium concentration by replacing the EGTA-containing medium with fresh medium (1.8 mM CaCl2) (23, 29). In some experiments, the fresh medium contained 100 µg/ml anti-E-cadherin antibody or mouse IgG purified from nonimmune serum. After selected time intervals of calcium restoration, cells were washed twice with ice-cold PBS and lysed to detect phospho-Akt and to assay p38 MAPK activity or were fixed for immunofluorescence.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

PI3K Activity Is Essential for Differentiation of Intestinal Epithelial Cells-- To investigate the role of PI3K in intestinal epithelial cell differentiation, we evaluated the impact of its inhibition on the spontaneous enterocytic differentiation of the human colon cancer cell line Caco-2/15. This cell line provides a unique and well characterized model for the study of intestinal epithelial differentiation because these cells undergo differentiation to a small bowel-like phenotype with microvilli, dome formation, and the expression of sucrase-isomaltase several days after reaching confluence (12-15). To block PI3K signaling, we used LY294002, a compound that acts as a competitive inhibitor of the adenosine triphosphate-binding site of PI3K and has been shown to cause specific inhibition with an IC50 of 1.4-5 µM in intact cells (30). Daily addition of 10 µM LY294002 beginning at confluence strongly attenuated the expression levels of two enterocytic differentiation markers, viz. sucrase-isomaltase and villin, compared with untreated cells at days 3, 6, and 12 post-confluence (Fig. 1A). Loss of PI3K activity did not interfere with overall protein expression, as shown by similar actin levels in LY294002-treated and untreated cells (Fig. 1A). To ascertain that the loss of differentiation marker expression was not a consequence of increased apoptosis, we evaluated the expression of poly(ADP-ribose) polymerase, a well known caspase-3 substrate (31), in cells treated with LY294002. As shown in Fig. 1A, chronic treatment of confluent Caco-2/15 cells with the PI3K inhibitor had no effect on poly(ADP-ribose) polymerase cleavage, suggesting that persistent inhibition of PI3K did not affect Caco-2/15 cell survival.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 1.   PI3K inhibition alters functional differentiation of human intestinal epithelial cells. A, confluent Caco-2/15 cells (day 0) were treated daily with (+) or without (-) 10 µM LY294002 and harvested at days 3, 6, and 12 post-confluence. Fifty µg of cell lysate were separated by SDS-PAGE, and proteins were analyzed by Western blotting to determine the expression levels of sucrase-isomaltase, villin, actin, and poly(ADP-ribose) polymerase (PARP). B, confluent Caco-2/15 cells (day 0) were transfected with 0.1 µg of sucrase-isomaltase reporter gene and incubated with or without 1-20 µM LY294002. The sucrase-isomaltase reporter gene vector was also cotransfected with 0.1 µg of pcDNA3 containing or not the dominant-negative (Delta p85) or constitutively active (p110*) form of PI3K. Luciferase activity was measured 36 h after transfection. The increase in luciferase activity was calculated relative to the level of sucrase-isomaltase/luciferase in the untreated control, a value set at 1. Results are the means ± S.E. of at least three separate experiments.

The role of PI3K in sucrase-isomaltase expression was further investigated by transient transfection of newly confluent Caco-2/15 cells with a luciferase reporter gene under the control of the human sucrase-isomaltase promoter. As shown in Fig. 1B, sucrase-isomaltase gene expression was inhibited in a dose-dependent manner by the PI3K inhibitor LY294002, with a maximal effect observed at 20 µM (91% inhibition). Furthermore, overexpression of a dominant-negative form of the regulatory p85 subunit (Delta p85) reduced sucrase-isomaltase gene expression by 50%. Conversely, overexpression of a constitutively active p110 subunit (p110*) slightly enhanced sucrase-isomaltase gene expression.

Caco-2/15 cell cultures were characterized by transmission electron microscopy day 14 post-confluence. As shown in Fig. 2 (panels 1, 3, and 5), post-confluent Caco-2/15 cells exhibited ultrastructural characteristics similar to those found in the intact villus epithelium, including well organized brush borders, terminal webs at the luminal aspect of absorptive cells, and typical junctional complexes. Interestingly, treatment of confluent Caco-2/15 cells with the PI3K inhibitor remarkably affected cell polarization and brush-border formation. Indeed, LY294002-treated cells exhibited a less polarized and flat phenotype compared with untreated cells (Fig. 2, panels 1 and 2). The morphology of the brush border was altered markedly, as visualized by a reduction in the number of microvilli (Fig. 2, panels 3 and 4). Interestingly, poorly defined apical junctional complexes were observed in LY294002-treated cells (Fig. 2, panels 5 and 6). Taken together, these results indicate that PI3K activity is necessary for functional and morphological differentiation of intestinal epithelial cells.


View larger version (119K):
[in this window]
[in a new window]
 
Fig. 2.   PI3K inhibition alters morphological differentiation of human intestinal epithelial cells. Caco-2/15 cells were treated from days 0 to 14 post-confluence with or without 10 µM LY294002. Cells were fixed in glutaraldehyde and osmium tetroxide before epoxy embedding for electronic microscopy analysis. Bars = 5 µm (panels 1 and 2), 500 nm (panels 3 and 4), and 200 nm (panels 5 and 6).

PI3K Transiently Controls Adherens Junction Integrity-- Cell-cell adhesion plays a crucial role in the polarization and differentiation of epithelial cells (2-4). Our observation that LY294002-treated cells exhibited a less polarized and differentiated phenotype as well as poorly defined apical junctions prompted us to investigate whether PI3K might control the assembly of adherens and tight junctions in Caco-2/15 cells. We performed E-cadherin and ZO-1 staining in a two-step experiment in which tight and adherens junctions of day 2 post-confluent Caco-2/15 cells were disrupted by chelating extracellular calcium and subsequently allowed to re-establish by restoration of extracellular calcium (23, 29) in the presence or absence of LY294002. The untreated cells showed typical honeycomb E-cadherin and ZO-1 staining (Fig. 3A, panels 1 and 5). After a 30-min EGTA treatment, cells became rounded, whereas E-cadherin and ZO-1 staining formed a diffuse ring at the cell periphery (Fig. 3A, panels 2 and 6). Following calcium restoration, E-cadherin and ZO-1 redistributed at the sites of cell-cell contact, and the cells reacquired their epithelial shape (Fig. 3A, panels 3 and 7), suggesting that tight and adherens junctions were almost completely reformed. However, in LY294002-treated cells, most of the immunoreactive E-cadherin remained diffusely distributed (Fig. 3A, panel 4). Interestingly, similar results were also noted in Caco-2/15 cells transiently transfected with the dominant-negative mutant of p85 (Fig. 3B), indicating that PI3K inhibition interfered with the assembly of adherens junctions. This phenomenon appears to be specific for adherens junctions because ZO-1 redistributed at the sites of cell-cell contact even in the presence of LY294002 (Fig. 3A, panel 8).


View larger version (59K):
[in this window]
[in a new window]
 
Fig. 3.   PI3K inhibition interferes with adherens junction assembly. A, day 1 post-confluent Caco-2/15 cell monolayers were serum-starved for 16 h and then treated with 4 mM EGTA for 30 min with (+) or without (-) 10 µM LY294002. The EGTA-containing medium was replaced with fresh calcium-containing medium for 30 min with or without the inhibitor. Cells were fixed for immunofluorescence and co-stained for E-cadherin and ZO-1 proteins. B, confluent Caco-2/15 cells (day 0) were cotransfected with 0.5 µg of pLHCX-GFP plasmid and 0.5 µg of pcDNA3 containing or not the dominant-negative form of PI3K (Delta p85). One day following transfection, cells were serum-starved for 16 h and treated with 4 mM EGTA for 30 min. The EGTA-containing medium was then replaced with fresh calcium-containing medium for 30 min. Cells were fixed for GFP fluorescence and immunofluorescence (IF) with anti-E-cadherin antibody. Bar = 10 µm.

Previous studies have shown that the E-cadherin and beta -catenin associated with functional adherens junctions are indirectly linked to the cytoskeleton (32). Thus, they cannot be extracted with a solution of 0.5% of the nonionic detergent Triton X-100, but are found in the insoluble fraction. Inhibition of PI3K resulted in a significant reduction in the proportion of E-cadherin and beta -catenin associated with the cytoskeleton after 16-72 h of treatment in newly confluent Caco-2/15 cells (Fig. 4A, upper panels). Total amounts of E-cadherin or beta -catenin proteins remained comparable. Interestingly, inhibition of PI3K activity by LY294002 or by ectopic expression of the dominant-negative mutant of p85 in newly confluent cells also led to a partial disruption of F-actin at the periphery of the cytoplasmic membrane (Fig. 4B, right panel) and to a drastic redistribution of total actin (Fig. 4C, right panel), respectively; expression of GFP alone, however, did not influence actin distribution (data not shown). It was also recently reported that the regulation of adherens junction assembly/disassembly is dependent upon cellular context and junction maturation (33, 34). To test the hypothesis that PI3K activity is also important for the maintenance of mature adherens junctions in differentiated cells, we performed Triton X-100 extraction on day 9 post-confluent cells. In this situation, PI3K inhibition did not interfere with the association of E-cadherin or beta -catenin with the cytoskeleton even after 72 h of treatment (Fig. 4A, lower panels). Overall, the results indicate that PI3K regulates E-cadherin and beta -catenin association with the cytoskeleton at the time cells reach confluence, suggesting that PI3K activity is involved in the assembly of E-cadherin-mediated cell-cell contacts rather than in the maintenance of mature adherens junctions.


View larger version (51K):
[in this window]
[in a new window]
 
Fig. 4.   PI3K inhibition interferes with association of adherens junction components with the cytoskeleton. A: upper panels, newly confluent (day 0) Caco-2/15 cells were treated with (+) or without (-) 10 µM LY294002 for 3-72 h, and cells were lysed at the end of the treatment. Lower panels, post-confluent Caco-2/15 cells were treated for 3-72 h with or without 10 µM LY294002, and cells were lysed at the same time on day 9 post-confluence. Total cell lysates (Total) and cytoskeleton-associated proteins (Insoluble) were separated by SDS-PAGE and subjected to immunoblotting for E-cadherin and beta -catenin. The results are representative of three independent experiments. B: newly confluent Caco-2/15 cells (day 0) were treated with or without 10 µM LY294002 for 48 h. Cells were fixed for immunofluorescence (IF) and stained for F-actin with fluorescein isothiocyanate-phalloidin. C: confluent Caco-2/15 cells (day 0) were cotransfected with 0.5 µg of pLHCX-GFP plasmid and 0.5 µg of pcDNA3 containing or not the dominant-negative form of PI3K (Delta p85). Two days following transfection, cells were fixed for GFP fluorescence and immunofluorescence with anti-total actin antibody. Representative results of in situ indirect immunofluorescence from three independent experiments are shown in B and C. Bars = 10 µm.

PI3K Is Recruited to Adherens Junctions in Confluent Caco-2/15 Cells-- To explore the possibility that PI3K is recruited in response to E-cadherin engagement and acts locally to control adherens junction formation in intestinal epithelial cells, subconfluent (day -2), confluent (day 0), and post-confluent (day 3) Caco-2/15 cells were double-labeled with antibodies to E-cadherin and the p85 regulatory subunit of PI3K. As illustrated in Fig. 5A (panel 1), expression of E-cadherin in subconfluent cells was detected at the sites of cell-cell contact, yet a significant amount of E-cadherin was diffusely distributed throughout the cytoplasm, which is a typical feature of immature junctions. In the same cells, p85 staining was restricted to the cytoplasm (Fig. 5A, panel 2), and no significant co-localization of E-cadherin and p85 was observed (panel 3). In newly confluent cells, E-cadherin accumulated at cell-cell interfaces in a typical honeycomb pattern characteristic of specialized and functional adherens junctions (Fig. 5A, panel 4). In the same cells, p85 was still partially localized in the cytoplasm, but was also clearly visible at the sites of cell-cell contact (Fig. 5A, panel 5, see arrowheads) with significant co-localization of E-cadherin and p85 (panel 6, see arrowheads). In day 3 post-confluent cells, p85 and E-cadherin were localized homogeneously at the cell-cell interfaces (Fig. 5A, panels 7 and 8), and the superimposition of both stainings showed a strong co-localization of these proteins (panel 9). We further studied the dynamics of E-cadherin/p85 interactions by co-immunoprecipitation assays. Fig. 5B shows that E-cadherin/p85 association in Caco-2/15 cells was significantly enhanced when the cells reached confluence (day 0) and further increased at day 3 post-confluence. Taken together, these results suggest that PI3K is recruited to E-cadherin-mediated cell-cell contacts at the time Caco-2/15 cells reach confluence.


View larger version (56K):
[in this window]
[in a new window]
 
Fig. 5.   E-cadherin engagement recruits PI3K p85 to the site of cell-cell contact. A, subconfluent, confluent (day 0), and day 3 post-confluent Caco-2/15 cells were fixed with methanol/acetone and permeabilized with a solution of 0.1% Triton X-100 for immunofluorescence and co-staining for PI3K p85 and E-cadherin proteins. Representative results of in situ indirect immunofluorescence from three independent experiments are shown. Bar = 10 µm. B, E-cadherin and PI3K p85 were immunoprecipitated (IP) from 600 µg of lysates from subconfluent, confluent (day 0), and day 3 post-confluent Caco-2/15 cells. Proteins of the immunoprecipitates were solubilized in Laemmli buffer and separated by SDS-PAGE. Proteins were analyzed by Western blotting (WB) to determine the amount of PI3K p85 and E-cadherin in the immunoprecipitates. The blots shown are representative of three independent experiments. alpha -E-cadherin, anti-E-cadherin antibody.

PI3K Inhibition Interferes with Activation of Akt and p38alpha MAPK-- We have previously demonstrated that p38alpha , an isoform of the p38 MAPK family, controls expression of some intestine-specific genes, viz. villin and sucrase-isomaltase (8). To investigate whether PI3K and p38alpha MAPK act in a common or parallel pathway in intestinal epithelial cells, we evaluated the expression and kinase activity of p38alpha in LY294002-treated Caco-2/15 cells. To determine the kinetics of PI3K inhibition by LY294002 in Caco-2/15 cells, we first analyzed the phosphorylation of Akt at Ser473, which is strongly dependent upon PI3K activity (22). As shown in Fig. 6 (upper panels), addition of LY294002 to newly confluent Caco-2/15 cells (day 0) did not influence Akt abundance, but strongly repressed Akt phosphorylation throughout the treatment. In contrast, p38alpha MAPK activity was inhibited only after 24, 48, and 72 h of treatment, whereas p38alpha protein expression remained unaffected by the PI3K inhibitor. This observation indicates that PI3K controls p38alpha MAPK activity in intestinal epithelial cells. In contrast to Akt, however, p38alpha MAPK does not seem to be a direct downstream effector of PI3K signaling in intestinal epithelial cells.


View larger version (75K):
[in this window]
[in a new window]
 
Fig. 6.   PI3K inhibition interferes with Akt phosphorylation and p38alpha MAPK activity in newly confluent Caco-2/15 cells. Upper panels, newly confluent (day 0) Caco-2/15 cells were treated with (+) or without (-) 10 µM LY294002 for 3-72 h, and cells were lysed at the end of the treatment. Lower panels, post-confluent differentiated Caco-2/15 cells were treated for 3-72 h with or without 10 µM LY294002, and cells were lysed at the same time at day 9 post-confluence. Cell lysates (400 µg) were immunoprecipitated with an antibody to p38alpha MAPK. The levels of immunoprecipitated p38alpha were analyzed by Western blotting, and the kinase activity of p38 was demonstrated by the phosphorylation of myelin basic protein (phospho-MBP). The phosphorylation of Akt was analyzed with an antibody that specifically recognizes Akt phosphorylated at Ser473 (phospho-Akt). The membrane was then reprobed with an antibody that recognizes Akt regardless of its phosphorylation state (total Akt). The results are representative of three independent experiments.

As demonstrated in Fig. 4A, newly confluent Caco-2/15 cells were more sensitive to PI3K inhibition than day 9 post-confluent cells (differentiated cells). Therefore, we evaluated the effect of LY294002 on p38alpha activity in late post-confluent cells. Treatment of day 9 post-confluent Caco-2/15 cells with LY294002 did not influence p38alpha activity even after 72 h of treatment (Fig. 6, lower panels), whereas Akt phosphorylation was again potently inhibited after 3 h of LY294002 treatment (lower panels). These results indicate that PI3K controls the activation of p38alpha MAPK at the time cells reach confluence and in newly confluent cells rather than the maintenance of p38 MAPK activity in differentiated cells.

E-cadherin Engagement Leads to p38alpha and Akt Activation-- We demonstrated that the kinetics of adherens junction disruption and p38alpha inactivation following LY294002 treatment in newly confluent Caco-2/15 cells were quite similar (Figs. 4A and 6, upper panels). This observation prompted us to investigate whether PI3K could indirectly control p38alpha MAPK activity by promoting E-cadherin-dependent cell-cell interactions. Hence, we monitored p38alpha activation in a calcium switch experiment (23, 29) in the presence or absence of LY294002. Removal of calcium from the culture medium of newly confluent Caco-2/15 cells resulted in disruption of the junctions (Fig. 3A) and clearly decreased Akt phosphorylation and p38 MAPK activity (Fig. 7A, second lane). Interestingly, Akt phosphorylation returned to the control level 60 min after calcium restoration, whereas p38alpha MAPK activity was almost completely re-established to the control level 5 min after calcium restoration, with an over-stimulation observed after 15 and 60 min (Fig. 7A, third through fifth lanes). PI3K inhibition abolished Akt phosphorylation and strongly attenuated p38alpha MAPK reactivation (Fig. 7A, sixth through eighth lanes). To verify that the modulation of Akt phosphorylation and p38alpha MAPK activation was actually due to adherens junction breakdown/reformation and not to experimental procedure, we blocked E-cadherin engagement during calcium restoration with an antibody known to block E-cadherin-mediated cell-cell interaction (35). As illustrated in Fig. 7B, the use of E-cadherin-blocking antibodies efficiently prevented Akt phosphorylation and p38alpha reactivation (monitored by Western blotting with an antibody recognizing the phosphorylated and active form of p38 MAPK) after 30 min of calcium restoration, indicating that E-cadherin engagement was necessary for Akt and p38alpha MAPK activation. Collectively, these results indicate that E-cadherin engagement stimulates p38alpha and Akt pathways through a PI3K-dependent mechanism.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 7.   E-cadherin engagement induces p38alpha MAPK and Akt activities. A, day 2 post-confluent Caco-2/15 cell monolayers were serum-starved for 16 h and then treated with 4 mM EGTA for 30 min with (+) or without (-)10 µM LY294002. The EGTA-containing medium was replaced with fresh calcium-containing medium for 5-60 min with or without 10 µM LY294002. The levels of immunoprecipitated p38alpha were analyzed by Western blotting, and the kinase activity of p38 was demonstrated by the phosphorylation of myelin basic protein (phospho-MBP). Akt phosphorylation was analyzed with an antibody that specifically recognizes Akt phosphorylated at Ser473 (phospho-Akt). The membrane was then reprobed with an antibody that recognized Akt regardless of its phosphorylation state (total Akt). B, day 2 post-confluent Caco-2/15 cell monolayers were serum-starved for 16 h and then treated with 4 mM EGTA for 30 min with 100 µg/ml anti-E-cadherin antibody (alpha -E-cadherin) or mouse IgG purified from nonimmune serum. The EGTA-containing medium was replaced with fresh calcium-containing medium for 30 min with 100 µg/ml anti-E-cadherin antibody or mouse IgG purified from nonimmune serum. Phosphorylation of p38 was analyzed with a specific antibody recognizing the active phosphorylated form of p38 (phospho-p38). Akt phosphorylation was analyzed with the antibody that specifically recognizes Akt phosphorylated at Ser473. The membranes were then reprobed with antibodies recognizing total p38 and Akt, respectively. The results are representative of three independent experiments.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Little is known regarding the mechanisms involved in the regulation of cell growth and differentiation in the human intestinal epithelium. The data presented in this report suggest that PI3K plays a crucial role in the control of differentiation events in this tissue. Indeed, we have demonstrated for the first time that PI3K is part of a signaling pathway necessary for functional and morphological differentiation of intestinal epithelial cells. Inhibition of PI3K decreased the expression of enterocyte markers, viz. sucrase-isomaltase and villin, and reduced cell polarization and brush-border formation. Furthermore, we demonstrated that E-cadherin engagement triggers the recruitment of PI3K and activates its signaling at the sites of cell-cell contact, and this activation appears to be essential for the assembly of adherens junctions and the association of their components with the cytoskeleton. Finally, we have provided evidence that one of the molecular events resulting from E-cadherin-mediated cellular aggregation is the activation of Akt and p38 MAPK in a PI3K-dependent manner.

A key question in intestinal development is what triggers the differentiation process. In this regard, it has been demonstrated that cell-cell junction systems, particularly adherens junctions, play an important role in the control of cell differentiation during intestinal ontogeny as well as during the continuous epithelial cell renewal in the mature organ. For instance, studies with E-cadherin knockout mice have revealed that E-cadherin-mediated cell adhesion is essential for the compaction of mesenchymal cells and their transition to a polarized epithelium (3, 36). In a chimeric-transgenic animal model, expression of a dominant-negative N/E-cadherin mutant in villous enterocytes resulted in perturbation of cell-cell adhesion associated with an increased enterocyte migration rate along the crypt-villus axis, loss of the differentiated polarized phenotype, and increased apoptosis (7). However, signaling components that relay the signal from adherens junction proteins to the nuclear targets for the control of intestine-specific gene expression remain elusive. Our observations showing that PI3K was recruited to and activated by E-cadherin-mediated cell-cell contacts in intestinal epithelial cells suggest that it may be one of these signaling components. Such stimulation of PI3K by E-cadherin-mediated cell-cell contacts has recently been reported in other epithelial cell types (23, 37). Furthermore, inhibition of PI3K activity by ectopic expression of a dominant-negative form of the regulatory p85 subunit (Delta p85) or by use of the LY294002 inhibitor repressed the expression of intestine-specific genes and delayed functional and morphological epithelial differentiation. Inhibition of PI3K was also found to alter adherens junction integrity in newly confluent monolayers of Caco-2/15 cells by reducing the amount of cytoskeleton-associated E-cadherin and beta -catenin at the site of cell-cell contact. Thus, we believe that E-cadherin-dependent PI3K activation acts as an intermediate in the formation of adherens junctions, suggesting a bidirectional regulation between PI3K activity and adherens junction assembly. Such bidirectional regulation has been recently described for E-cadherin and Rac/Cdc42 (38-40). Taken together, these data indicate that PI3K plays an important role in regulating the integrity of adherens junctions, which in turn seems to be crucial for the efficient differentiation of intestinal epithelial cells. The recent demonstration that PI3K is involved in three-dimensional morphogenesis and tissue-specific differentiation in the mammary gland (28) strengthens this hypothesis.

The mechanism by which PI3K inhibition impairs adherens junctions is unknown. In mammary epithelial cells, this response appears to be mediated by changes at the level of the actin cytoskeleton (28). In this regard, our data indeed suggest that PI3K activity regulates the recruitment of F-actin at the site of cell-cell contact. It is known that phosphatidylinositol 3,4,5-triphosphate, a lipid product of PI3K, can recruit and activate the GTP exchange factor for Rac, which is required for adherens junction formation in Madin-Darby canine kidney cells and keratinocytes (41, 42), whereas Rac promotes the recruitment of F-actin to these junctions (42). These observations raise the possibility that a PI3K/Rac signaling pathway controls the integrity of adherens junctions in intestinal epithelial cells. However, in well polarized Caco-2/15 cells with mature intercellular junctions, we have observed that PI3K inhibition no longer interfered with the association of E-cadherin and beta -catenin with the cytoskeleton. It is noteworthy that PI3K inhibition has no effect on the expression of differentiation markers such as sucrase-isomaltase and villin in well polarized Caco-2/15 cells.2 PI3K may thus act locally to control the early establishment of E-cadherin-mediated cell-cell contact and the initiation of the differentiation program rather than their maintenance. These observations are consistent with the fact that properties of E-cadherin-mediated cell-cell contact appear to be modulated by junction maturation (33). For instance, the regulation of E-cadherin function by Rac is progressively lost as the E-cadherin junction matures (33, 34).

In addition to its participation in E-cadherin-mediated epithelial cell adhesion, beta -catenin is a key player in the APC/Wnt signaling pathway. In normal colonic epithelial cells, APC, in combination with glycogen-synthase kinase-3beta and axin, regulates free cytoplasmic beta -catenin levels by binding to and targeting beta -catenin for degradation by ubiquitination-dependent proteolysis. This regulates the availability of free beta -catenin for binding with the T-cell factor/lymphoid enhancer family of transcription factors (43). In the absence of a Wnt signal, APC promotes the degradation of cytoplasmic beta -catenin, whereas in the presence of a Wnt signal, beta -catenin accumulates in the cytoplasm, translocates to the nucleus, and coordinates with the T-cell factor/lymphoid enhancer to activate gene transcription (44). Our observation that the inhibition of PI3K led to a decreased association of E-cadherin and beta -catenin with the cytoskeleton fraction could suggest a possible regulation of the APC/Wnt/beta -catenin signaling pathway by PI3K. However, inhibition of PI3K activity by ectopic expression of a dominant-negative form of p85 (Delta p85) or by use of the LY294002 inhibitor did not enhance pTOPFLASH activity, a T-cell factor promoter/luciferase reporter plasmid that directly assays beta -catenin/T-cell factor activity (45) (data not shown). Furthermore, our data shown in Fig. 4A clearly indicate that the total cellular amounts of beta -catenin protein remained comparable following PI3K inhibition, suggesting that beta -catenin was not targeted for degradation in the proteasome. Taken together, these data suggest that PI3K does not regulate the Wnt/beta -catenin signaling pathway in newly confluent Caco-2/15 cells. However, future studies will be needed to further clarify the involvement of PI3K in the regulation of this pathway in intestinal epithelial cells.

Another interesting finding from this work is the demonstration that E-cadherin engagement led to a PI3K-dependent activation of Akt. Akt stimulation has been involved in skeletal muscle differentiation (46), which also depends on PI3K (19, 20). Such a contribution of Akt to intestinal epithelial cell differentiation would be interesting to explore. However, Akt has been implicated in the control of cell survival and thereby could mediate the protective action of E-cadherin-mediated cell-cell contacts against apoptosis (6, 37, 47).

Our study also provides evidence for the first time that E-cadherin-mediated cell-cell contact triggers p38 MAPK cascade activation. The p38alpha MAPK pathway was demonstrated previously to be an important modulator of enterocyte differentiation (8). Thus, it seems that PI3K and p38alpha MAPK act in a common pathway in intestinal epithelial cells toward the regulation of their differentiation. We provided several indications that PI3K-dependent activation of p38alpha MAPK relies on the ability of PI3K to promote the assembly and integrity of adherens junctions. First, a good correlation of the kinetics of adherens junction disruption with a decrease in p38alpha MAPK activity was observed following PI3K inhibition. Second, in well polarized cells, PI3K inhibition did not alter adherens junction integrity or affect p38alpha activity. And third, PI3K inhibition, which inhibited adherens junction but not tight junction assembly, also attenuated E-cadherin-dependent activation of p38alpha . Therefore, the ability of PI3K to control adherens junction formation and p38alpha activity, known to control intestine-specific gene transcription (8), confers to this kinase a central role in the promotion of intestinal epithelial cell differentiation. However, the mechanism relating PI3K to adherens junction integrity and p38alpha MAPK activation remains to be elucidated.

The complexity of the PI3K-dependent pathways is further emphasized by the recent work of Wang et al. (48), who showed that PI3K inhibition through overexpression of PTEN (which directly dephosphorylates the D3 phosphate group of the lipid products of PI3K) or wortmannin treatment results in an increase in alkaline phosphatase and sucrase-isomaltase enzymatic activities, suggesting a regulatory effect of this pathway on intestinal cell differentiation. Although it cannot be excluded that these contradictory effects are the result of the use of distinct cell lines, and they are not without precedent (15, 49), the fact that PTEN effects were observed mostly in the presence of butyrate is a good indication that alternative pathways may exist.

In conclusion, migration of intestinal epithelial cells from the crypts to the villus tips involves programming for proliferation- and differentiation-related events. A key question in intestinal development is what triggers cell cycle arrest and the differentiation process. In vitro cell culture experiments have shown that cell-cell contact can trigger differentiation and therefore substitute the in vivo signal. The data presented herein indicate that PI3K signaling plays an important role in initiating intestinal epithelial cell differentiation. In this model (Fig. 8), E-cadherin engagement recruits and activates PI3K signaling. This activation promotes the assembly of adherens junction components with the cytoskeleton, which in turn activates the p38 MAPK cascade, enhancing the transactivation capacity of CDX2. Rac is a likely candidate as a signaling intermediate because, as reported in other cell types, it could be a downstream effector of PI3K (41) and an upstream activator of the p38 MAPK module (50). However, regardless of the exact mechanism, the ability of PI3K to control adherens junction formation and p38 MAPK activity confers to PI3K a central role in the promotion of intestinal epithelial cell differentiation.


View larger version (55K):
[in this window]
[in a new window]
 
Fig. 8.   Schematic of proposed pathways involved in the regulation of functional and morphological differentiation of intestinal epithelial cells based on the findings of this study. In this model, E-cadherin engagement recruits and activates PI3K signaling. This activation of PI3K might increase the amount of F-actin at the sites of cell-cell contact (through Rac?) and thereby promote the assembly of adherens junction components with the cytoskeleton. The ability of PI3K to promote the assembly and integrity of adherens junctions allows the activation of p38alpha MAPK, which enhances the transactivation capacity of CDX2 for intestine-specific genes. TJ, tight junctions; AJ, adherens junctions; D, desmosomes; BB, brush border; W, terminal web of actin; SI, sucrase-isomaltase.


    ACKNOWLEDGEMENTS

We acknowledge the expert technical assistance of Pierre Magny, Denis Martel, Anne Vézina, Dominique Jean, and Claude Deschênes. We thank Elizabeth Herring and Amy Svotelis for critical reading of the manuscript. We also acknowledge Dr. Jacques Landry for kindly providing rabbit anti-p38alpha MAPK antibody. Special thanks go to Dr. Claude Asselin for constant encouragement, judicious comments, and excellent collaboration in the course of this work.

    FOOTNOTES

* This work was supported by Canadian Institutes of Health Research Grants MT-14405 and GR-15186.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Student Scholar from the Fonds de la Recherche en Santé du Québec.

§ Scholar from the Fonds de la Recherche en Santé du Québec. To whom correspondence should be addressed. Tel.: 819-564-5271; Fax: 819-564-5320; E-mail: nrivard@courrier.usherb.ca.

Published, JBC Papers in Press, December 27, 2001, DOI 10.1074/jbc.M110235200

2 P. Laprise and N. Rivard, unpublished data.

    ABBREVIATIONS

The abbreviations used are: MAPK, mitogen-activated protein kinase; PI3K, phosphatidylinositol 3-kinase; ZO-1, zonula occludens-1; PBS, phosphate-buffered saline; GFP, green fluorescent protein; PIPES, 1,4-piperazinediethanesulfonic acid; APC, adenomatous polyposis coli.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Babyatsky, M. W., and Podolsky, D. K. (1999) in Growth and Development of the Gastrointestinal Tract (Yamada, T., ed), 3rd Ed. , pp. 547-584, J. B. Lippincott Co., Philadelphia
2. Takeichi, M. (1995) Curr. Opin. Cell Biol. 7, 619-627[CrossRef][Medline] [Order article via Infotrieve]
3. Larue, L., Antos, C., Butz, S., Huber, O., Delmas, V., Dominis, M., and Kemler, R. (1996) Development 122, 3185-3194[Abstract]
4. Vleminckz, K., and Kemler, R. (1999) Bioessays 21, 211-220[CrossRef][Medline] [Order article via Infotrieve]
5. Jou, T. S., Stewart, D. B., Stappert, J., Nelson, W. J., and Mars, J. A. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 5067-5071[Abstract/Free Full Text]
6. Hermiston, M. L., and Gordon, J. I. (1995) J. Cell Biol. 129, 489-506[Abstract/Free Full Text]
7. Hermiston, M. L., and Gordon, J. I. (1995) Science 270, 1203-1207[Abstract/Free Full Text]
8. Houde, M., Laprise, P., Jean, D., Blais, M., Asselin, C., and Rivard, N. (2001) J. Biol. Chem. 276, 21885-21894[Abstract/Free Full Text]
9. Traber, P. G., and Silberg, D. G. (1996) Annu. Rev. Physiol. 58, 275-297[CrossRef][Medline] [Order article via Infotrieve]
10. Evers, B. M., Ko, T. C., Li, J., and Thompson, E. A. (1996) Am. J. Physiol. 271, G722-G727[Abstract/Free Full Text]
11. Deschênes, C., Vézina, A., Beaulieu, J.-F., and Rivard, N. (2001) Gastroenterology 120, 423-438[CrossRef][Medline] [Order article via Infotrieve]
12. Pinto, M., Robine-Leon, S., Appay, M. D., Kedinger, M., Triadou, N., Bussaulx, N., Lacroix, B., Simon-Assman, P., Haffen, K., Fogh, J., and Zweibaum, A. (1983) Biol. Cell 47, 323-330
13. Vachon, P. H., and Beaulieu, J.-F. (1992) Gastroenterology 103, 414-423[Medline] [Order article via Infotrieve]
14. Peterson, M. D., Bement, W. M., and Mooseker, M. S. (1993) J. Cell Sci. 105, 461-472[Abstract]
15. Aliaga, J. C., Deschênes, C., Beaulieu, J.-F., Calvo, E. L., and Rivard, N. (1999) Am. J. Physiol. 277, G631-G641[Abstract/Free Full Text]
16. Nebrada, A. R., and Porras, A. (2000) Trends Biochem. Sci. 26, 257-260
17. Cuenda, A., and Cohen, P. (1999) J. Biol. Chem. 274, 4341-4346[Abstract/Free Full Text]
18. Zetser, A., Gredinger, E., and Bengal, E. (1999) J. Biol. Chem. 274, 5193-5200[Abstract/Free Full Text]
19. Chun, Y. K., Kim, J., Kwon, S., Choi, S. H., Hong, F., Moon, K., Kim, J. M., Choi, S. L., Kim, B. M., and Kim, S. S. (2000) Biochem. Biophys. Res. Comm. 276, 502-507[CrossRef][Medline] [Order article via Infotrieve]
20. Li, Y., Jiang, B., Ensign, W. Y., Vogt, P. K., and Han, J. (2000) Cell. Signal. 11-12, 751-757
21. Rameh, L. E., and Cantley, L. C. (1999) J. Biol. Chem. 274, 8347-8350[Free Full Text]
22. Datta, S. R., Brunet, A., and Greenberg, M. E. (1999) Genes Dev. 13, 2905-2927[Free Full Text]
23. Pece, S., Chiariello, M., Murga, C., and Gutkind, J. S. (1999) J. Biol. Chem. 274, 19347-19351[Abstract/Free Full Text]
24. Guay, J., Lambert, H., Gingras-Breton, G., Lavoie, J. N., Huot, J., and Landry, J. (1997) J. Cell Sci. 110, 357-368[Abstract]
25. Beaulieu, J.-F., Nichols, B., and Quaroni, A. (1989) J. Biol. Chem. 264, 20000-20011[Abstract/Free Full Text]
26. Beaulieu, J.-F., and Quaroni, A. (1991) Biochem. J. 280, 599-608
27. Peterson, G. L. (1977) Anal. Biochem. 83, 346-356[CrossRef][Medline] [Order article via Infotrieve]
28. Somasiri, A., Colleen, W., Ellchuk, T., Turley, S., and Rosekelley, C. D. (2000) Differentiation 66, 116-1125[CrossRef][Medline] [Order article via Infotrieve]
29. Volberg, T., Geiger, B., Kartenbeck, J., and Franke, W. W. (1986) J. Cell Biol. 102, 1832-1842[Abstract/Free Full Text]
30. Vlahos, C. J., Matter, W. F., Hui, K. Y., and Brown, R. F. (1994) J. Biol. Chem. 269, 5241-5248[Abstract/Free Full Text]
31. Casciola-Rosen, L., Nicholson, D. W., Chong, T., Rowan, K. R., Thornberry, N. A., Miller, D. K., and Rosen, A. (1996) J. Exp. Med. 183, 1957-1964[Abstract/Free Full Text]
32. Hülsken, J., Birchmeier, W., and Behrens, J. (1994) J. Cell Biol. 127, 2061-2069[Abstract/Free Full Text]
33. Braga, V. M., Del Maschio, A., Machesky, L., and Dejana, E. (1999) Mol. Biol. Cell 10, 9-22[Abstract/Free Full Text]
34. Akhtar, N., and Hotchin, N. A. (2001) Mol. Biol. Cell 12, 847-862[Abstract/Free Full Text]
35. Watabe, M., Nagafuchi, A., Tsukita, S., and Takeichi, M. (1994) J. Cell Biol. 127, 247-256[Abstract/Free Full Text]
36. Riethmacher, D., Brinkman, V., and Birchmeier, C. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 855-859[Abstract/Free Full Text]
37. Bergin, E., Levine, J. S., Koh, J. S., and Lieberthal, W. (2000) Am. J. Physiol. 278, F758-F768[Abstract/Free Full Text]
38. Braga, V. M. (1999) Mol. Pathol. 52, 197-202[Abstract]
39. Kim, S. H., Zhigang, L., and Sacks, D. B. (2000) J. Biol. Chem. 275, 36999-37005[Abstract/Free Full Text]
40. Nakagawa, M., Fukata, M., Yamaga, M., Itoh, N., and Kaibuchi, K. (2001) J. Cell Sci. 114, 1829-1838[Abstract]
41. Braga, V. M., Machesky, L. M., Hall, A., and Hotchin, N. A. (1997) J. Cell Biol. 137, 1421-1431[Abstract/Free Full Text]
42. Takaishi, K., Sasaki, T., Kotani, H., Nishioka, H., and Takai, Y. (1997) J. Cell Biol. 139, 1047-1059[Abstract/Free Full Text]
43. Mimori-Kiyosue, Y., and Tsukita, S. (2001) J. Cell Biol. 154, 1105-1109[Abstract/Free Full Text]
44. Ikeda, S., Kishida, S., Yamamoto, H., Murai, H., and Koyama, S. (1998) EMBO J. 17, 1371-1384[CrossRef][Medline] [Order article via Infotrieve]
45. Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., and Clevers, H. (1997) Science 275, 1784-1787[Abstract/Free Full Text]
46. Jiang, B. H., Aoki, M., Zheng, J. Z., Li, J., and Vogt, P. K. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 2077-2081[Abstract/Free Full Text]
47. Peluso, J. J., Pappalardo, A., and Fernandez, G. (2001) Biol. Reprod. 64, 1183-1190[Abstract/Free Full Text]
48. Wang, Q., Wang, X., Hernandez, A., Kim, S., and Evers, B. M. (2001) Gastroenterology 120, 1381-1392[CrossRef][Medline] [Order article via Infotrieve]
49. Taupin, D., and Podolsky, D. K. (1999) Gastroenterology 116, 1072-1080[CrossRef][Medline] [Order article via Infotrieve]
50. Zhang, S., Han, J., Sells, M. A., Chernoff, J., Knaus, U. G., Ulevitch, R. J., and Bokoch, G. M. (1995) J. Biol. Chem. 270, 23934-23936[Abstract/Free Full Text]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Physiol.Home page
Y. Feng, X. Sun, H. Yang, and D. H. Teitelbaum
Dissociation of E-cadherin and {beta}-catenin in a mouse model of total parenteral nutrition: a mechanism for the loss of epithelial cell proliferation and villus atrophy
J. Physiol., February 1, 2009; 587(3): 641 - 654.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M.-L. Wang, S. A. Keilbaugh, T. Cash-Mason, X. C. He, L. Li, and G. D. Wu
Immune-mediated signaling in intestinal goblet cells via PI3-kinase- and AKT-dependent pathways
Am J Physiol Gastrointest Liver Physiol, November 1, 2008; 295(5): G1122 - G1130.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Hu, Y. Wang, W. V. Graham, L. Su, M. W. Musch, and J. R. Turner
MAPKAPK-2 Is a Critical Signaling Intermediate in NHE3 Activation Following Na+-Glucose Cotransport
J. Biol. Chem., August 25, 2006; 281(34): 24247 - 24253.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
V. P. Ramsauer, V. Pino, A. Farooq, C. A. Carothers Carraway, P. J.I. Salas, and K. L. Carraway
Muc4-ErbB2 Complex Formation and Signaling in Polarized CACO-2 Epithelial Cells Indicate That Muc4 Acts as an Unorthodox Ligand for ErbB2
Mol. Biol. Cell, July 1, 2006; 17(7): 2931 - 2941.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. R. Thrash, C. W. Menges, R. H. Pierce, and D. J. McCance
AKT1 Provides an Essential Survival Signal Required for Differentiation and Stratification of Primary Human Keratinocytes
J. Biol. Chem., April 28, 2006; 281(17): 12155 - 12162.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Peignon, S. Thenet, C. Schreider, S. Fouquet, A. Ribeiro, E. Dussaulx, J. Chambaz, P. Cardot, M. Pincon-Raymond, and J. Le Beyec
E-cadherin-dependent Transcriptional Control of Apolipoprotein A-IV Gene Expression in Intestinal Epithelial Cells: A ROLE FOR THE HEPATIC NUCLEAR FACTOR 4
J. Biol. Chem., February 10, 2006; 281(6): 3560 - 3568.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
F.-P. Gendron, S. Mongrain, P. Laprise, S. McMahon, C. M. Dubois, M. Blais, C. Asselin, and N. Rivard
The CDX2 transcription factor regulates furin expression during intestinal epithelial cell differentiation
Am J Physiol Gastrointest Liver Physiol, February 1, 2006; 290(2): G310 - G318.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
N. T. Chartier, M. Laine, S. Gout, G. Pawlak, C. A. Marie, P. Matos, M. R. Block, and M. R. Jacquier-Sarlin
Laminin-5-integrin interaction signals through PI 3-kinase and Rac1b to promote assembly of adherens junctions in HT-29 cells
J. Cell Sci., January 1, 2006; 119(1): 31 - 46.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Kim, A. J. Schein, and J. A. Nadel
E-cadherin promotes EGFR-mediated cell differentiation and MUC5AC mucin expression in cultured human airway epithelial cells
Am J Physiol Lung Cell Mol Physiol, December 1, 2005; 289(6): L1049 - L1060.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. K. Y. Siu, C.-h. Wong, W. M. Lee, and C. Y. Cheng
Sertoli-Germ Cell Anchoring Junction Dynamics in the Testis Are Regulated by an Interplay of Lipid and Protein Kinases
J. Biol. Chem., July 1, 2005; 280(26): 25029 - 25047.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
F. Hollande, A. Shulkes, and G. S. Baldwin
Signaling the Junctions in Gut Epithelium
Sci. Signal., March 29, 2005; 2005(277): pe13 - pe13.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. S. Alexander and T. Ando
Density-dependent control of MAdCAM-1 and chronic inflammation. Focus on "Mechanisms of MAdCAM-1 gene expression in human intestinal microvascular endothelial cells"
Am J Physiol Cell Physiol, February 1, 2005; 288(2): C243 - C244.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Dufour, M.-J. Demers, D. Gagne, A. B. Dydensborg, I. C. Teller, V. Bouchard, I. Degongre, J.-F. Beaulieu, J. Q. Cheng, N. Fujita, et al.
Human Intestinal Epithelial Cell Survival and Anoikis: DIFFERENTIATION STATE-DISTINCT REGULATION AND ROLES OF PROTEIN KINASE B/Akt ISOFORMS
J. Biol. Chem., October 15, 2004; 279(42): 44113 - 44122.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
I. Gonzalez, G. Tripathi, E. J. Carter, L. J. Cobb, D. A. M. Salih, F. A. Lovett, C. Holding, and J. M Pell
Akt2, a Novel Functional Link between p38 Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase Pathways in Myogenesis
Mol. Cell. Biol., May 1, 2004; 24(9): 3607 - 3622.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. G. Arndt, N. Suzuki, N. J. Avdi, K. C. Malcolm, and G. S. Worthen
Lipopolysaccharide-induced c-Jun NH2-terminal Kinase Activation in Human Neutrophils: ROLE OF PHOSPHATIDYLINOSITOL 3-KINASE AND Syk-MEDIATED PATHWAYS
J. Biol. Chem., March 19, 2004; 279(12): 10883 - 10891.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Blanchard, S. Durual, M. Estienne, K. Bouzakri, M. H. Heim, N. Blin, and J.-C. Cuber
IL-4 and IL-13 Up-Regulate Intestinal Trefoil Factor Expression: Requirement for STAT6 and De Novo Protein Synthesis
J. Immunol., March 15, 2004; 172(6): 3775 - 3783.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Laprise, A. Viel, and N. Rivard
Human Homolog of Disc-large Is Required for Adherens Junction Assembly and Differentiation of Human Intestinal Epithelial Cells
J. Biol. Chem., March 12, 2004; 279(11): 10157 - 10166.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. I. Morin and J. Huot
Recent Advances in Stress Signaling in Cancer
Cancer Res., March 1, 2004; 64(5): 1893 - 1898.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
D. Okamura, T. Kimura, T. Nakano, and Y. Matsui
Cadherin-mediated cell interaction regulates germ cell determination in mice
Development, December 29, 2003; 130(26): 6423 - 6430.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
H Sheng, J Shao, C M Townsend jr, and B M Evers
Phosphatidylinositol 3-kinase mediates proliferative signals in intestinal epithelial cells
Gut, October 1, 2003; 52(10): 1472 - 1478.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
J. C. Fleet, L. Wang, O. Vitek, B. A. Craig, and H. J. Edenberg
Gene expression profiling of Caco-2 BBe cells suggests a role for specific signaling pathways during intestinal differentiation
Physiol Genomics, March 18, 2003; 13(1): 57 - 68.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. H. Chong, Y. J. Shin, and Y.-H. Suh
Cyclic AMP Inhibition of Tumor Necrosis Factor alpha Production Induced by Amyloidogenic C-Terminal Peptide of Alzheimer's Amyloid Precursor Protein in Macrophages: Involvement of Multiple Intracellular Pathways and Cyclic AMP Response Element Binding Protein
Mol. Pharmacol., March 1, 2003; 63(3): 690 - 698.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/10/8226    most recent
M110235200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laprise, P.
Right arrow Articles by Rivard, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laprise, P.
Right arrow Articles by Rivard, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement